Contact
QR code for the current URL

Story Box-ID: 192643

Cytos Biotechnology AG Wagistrasse 25 8952 Schlieren, Switzerland http://www.cytos.com
Contact Ms Dr. Claudine Blaser +41 44 733 47 20
Company logo of Cytos Biotechnology AG
Cytos Biotechnology AG

Wichtige Ereignisse Q2 2008

(PresseBox) (Schlieren, )
.
- Cytos Biotechnology erhält von Novartis eine Entschädigung von CHF 5 Mio. für die Alzheimer- Kollaboration, da der Impfstoff-Kandidat CAD106 in der Entwicklung in die Phase IIa vorangebracht wird
- NIC002-Entwicklung geht weiter. Novartis beginnt eine Phase II-Studie mit dem Impfstoff- Kandidaten zur Behandlung der Nikotinsucht
- Bevorstehender Anlass Qjbwndkjwval-Srsrdfzicmhb hk znd «Hiq. Ojmuissag Tnuerbgltv Zajrrbcvbq»
Inactive

The publishing company has not yet activated this story.

You still have access to the unabridged text if you have free PresseBox reader access.

Log in or register free of charge
The publisher indicated in each case (see company info by clicking on image/title or company info in the right-hand column) is solely responsible for the stories above, the event or job offer shown and for the image and audio material displayed. As a rule, the publisher is also the author of the texts and the attached image, audio and information material. The use of information published here is generally free of charge for personal information and editorial processing. Please clarify any copyright issues with the stated publisher before further use. In case of publication, please send a specimen copy to service@pressebox.de.
Important note:

Systematic data storage as well as the use of even parts of this database are only permitted with the written consent of unn | UNITED NEWS NETWORK GmbH.

unn | UNITED NEWS NETWORK GmbH 2002–2024, All rights reserved

The publisher indicated in each case (see company info by clicking on image/title or company info in the right-hand column) is solely responsible for the stories above, the event or job offer shown and for the image and audio material displayed. As a rule, the publisher is also the author of the texts and the attached image, audio and information material. The use of information published here is generally free of charge for personal information and editorial processing. Please clarify any copyright issues with the stated publisher before further use. In case of publication, please send a specimen copy to service@pressebox.de.